Precigen, Inc. (PGEN)

NASDAQ

$4.60

$+0.12

(+2.59%)

Pre-Market

Precigen, Inc. (PGEN) Live Price Chart

Last updated: ⁦2026-11-11 13:45:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Precigen, Inc. (PGEN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.60, with a market capitalization of $1.70B and a P/E ratio of 69.49. Over the past 52 weeks, its price has ranged from $3.04 to $8.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.70B
Open	$4.48
Day's High	$11.10
Day's Low	$0.65
Previous Close	$4.52
Volume	7.16K
Average Volume	5.89M
P/E Ratio	69.49
52-Week High	$8.98
52-Week Low	$3.04
Dividend Yield	--
Earnings Date	--

Precigen, Inc. (PGEN) Pre-Market Stock Price

Precigen, Inc. (PGEN) is trading at $4.60 in pre-market trading as of 2026-11-11 13:34:00, up 1.66% ($0.08) from the previous close of $4.52

Pre-market trading shows how investors are pricing PGEN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Precigen, Inc. (PGEN) 7-Day Stock Price Change

Over the past seven days, Precigen, Inc. (PGEN) moved from $5.14 to $4.60, representing a decline of 10.60% ($0.54).

The stock traded between $3.92 and $5.48 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 13.08 million shares, up versus the previous seven-day period, indicating higher trading activity.

PGEN 52-Week Price Position

Position in Range: 26.2%

52W Low$3.04

52W High$8.98

PGEN is currently trading at $4.60, placing it 26.2% of the way from its 52-week low of $3.04 to its 52-week high of $8.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Precigen, Inc. (PGEN)?

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Precigen, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	47
Exchange	NASDAQ
Company Website	http://www.precigen.com

How to Buy Precigen, Inc. (PGEN) Stock on MEXC

Eligible investors can buy real shares of Precigen, Inc. (PGEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PGEN and Place Your Order

Open the RealStocks trading page and search for PGEN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Precigen, Inc. (PGEN) stock price today?

Precigen, Inc. (PGEN) is currently trading at $ 4.60, up 1.66% ($0.08) from the previous close of $ 4.52. Intraday prices update in real time during regular trading hours.

2.Is PGEN stock going up or down today?

As of 2026-11-11 13:34:00, PGEN is trading at $ 4.60, up 1.66% ($0.08) from its previous close of $ 4.52. The stock has traded between $ 0.65 and $ 11.10 during today’s regular session. Past price movements do not guarantee future results.

3.What is PGEN pre-market price?

As of 2026-11-11 13:34:00, PGEN is trading at $ 4.60 in pre-market trading, up 1.66% ($0.08) from the previous close of $ 4.52. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PGEN after-hours price?

As of 2026-11-11 13:34:00, PGEN is trading at $ 4.48 in after-hours trading, down 0.91% ($0.04) from the regular-session close of $ 4.52. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PGEN stock trading now?

PGEN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PGEN sit relative to its 52-week high and low?

Over the past 52 weeks, PGEN has traded between a low of $ 3.04 and a high of $ 8.98. At $ 4.60, the stock is positioned 26.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Precigen, Inc. in?

Precigen, Inc. (PGEN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Precigen, Inc.'s market capitalization and where is it listed?

Precigen, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.70B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PGEN valued in terms of P/E ratio and EPS?

PGEN trades at a P/E ratio of 69.49, based on trailing-twelve-month EPS of $ 0.07. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Precigen, Inc. pay a dividend?

Precigen, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.